Atlas Capital Advisors »

Nektar Therapeutics shares owned by Atlas Capital Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Atlas Capital Advisors from 13F filings

Historical chart of Atlas Capital Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Atlas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Atlas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.0k 40 25.83

More positions owned by Atlas Capital Advisors

Procter Gamble Equity (PG)
Vanguard European Stock ETF Exchange Traded Fund (VGK)
Palomar Holdings Equity (PLMR)
Vanguard Ftse All-Wld Ex-US Small Cap ETF Exchange Traded Fund (VSS)
SPDR Emerging Market ETF Exchange Traded Fund (SPEM)
Microsoft Corp Equity (MSFT)
SPDR S P Info Technology ETF Exchange Traded Fund (XLK)
Apple Equity (AAPL)
SPDR S P Financial ETF Exchange Traded Fund (XLF)
Schwab Intl Small-Cap Equity ETF Exchange Traded Fund (SCHC)
iShares Edge MSCI Intl ETF Exchange Traded Fund (IMTM)
Spdr S P 500 Etf Exchange Traded Fund (SPY)
Amazon Equity (AMZN)
Vanguard Information Technology ETF Exchange Traded Fund (VGT)
Vanguard Financials ETF Exchange Traded Fund (VFH)

View all positions for Atlas Capital Advisors

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics